# EDGAR Filing Document

**Accession Number:** 0000778108
**File Stem:** 0001752724-25-207533
**Filing Date:** 2025-8
**Character Count:** 64337
**Document Hash:** f456954caa0728e52318fd783d56d707
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-207533.hdr.sgml**: 20250827

**ACCESSION NUMBER**: 0001752724-25-207533

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250827

**DATE AS OF CHANGE**: 20250827

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DELAWARE GROUP EQUITY FUNDS IV
- **CENTRAL INDEX KEY:** 0000778108

**ORGANIZATION NAME:**
- **EIN:** 232369628
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-04413
- **FILM NUMBER:** 251261585

**BUSINESS ADDRESS:**
- **STREET 1:** 100 INDEPENDENCE
- **STREET 2:** 610 MARKET STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19106-2354
- **BUSINESS PHONE:** 18005231918

**MAIL ADDRESS:**
- **STREET 1:** 100 INDEPENDENCE
- **STREET 2:** 610 MARKET STREET
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19106-2354

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELAWARE GROUP EQUITY FUNDS IV INC
- **DATE OF NAME CHANGE:** 19970128

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELAWARE GROUP DELCAP FUND INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DELCAP FUND INC
- **DATE OF NAME CHANGE:** 19880929

## Series and Classes Contracts Data

### Macquarie Healthcare Fund (Series ID: S000018873)

| Class ID   | Class Name          | Ticker Symbol   |
|:---|:---|:---|
| C000052257 | Class A             | DLHAX           |
| C000052258 | Class C             | DLHCX           |
| C000052259 | Class R             | DLRHX           |
| C000052260 | INSTITUTIONAL CLASS | DLHIX           |

## Nport-Ex

Schedule of investments

Macquarie Healthcare Fund June 30, 2025 (Unaudited)

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks — 99.44%♣** | &nbsp;&nbsp;**Common Stocks — 99.44%♣** | &nbsp;&nbsp;**Common Stocks — 99.44%♣** |
| &nbsp;&nbsp;Biotechnology — 38.33% | &nbsp;&nbsp;Biotechnology — 38.33% | &nbsp;&nbsp;Biotechnology — 38.33% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AbbVie | &nbsp;&nbsp;&nbsp;&nbsp;125000 | &nbsp;&nbsp;$23202500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ACADIA Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;92648 | &nbsp;&nbsp;&nbsp;&nbsp; 1998417 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Akero Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;39478 | &nbsp;&nbsp;&nbsp;&nbsp; 2106546 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alkermes † | &nbsp;&nbsp;&nbsp;&nbsp;300000 | &nbsp;&nbsp;&nbsp;&nbsp; 8583000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Allogene Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;146779 | &nbsp;&nbsp;&nbsp;&nbsp; 165860 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alnylam Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;30000 | &nbsp;&nbsp;&nbsp;&nbsp; 9782700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Altimmune † | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 387000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amarin ADR † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9500 | &nbsp;&nbsp;&nbsp;&nbsp; 154090 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amgen | &nbsp;&nbsp;&nbsp;&nbsp;77000 | &nbsp;&nbsp;&nbsp;&nbsp; 21499170 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AnaptysBio † | &nbsp;&nbsp;&nbsp;&nbsp;93732 | &nbsp;&nbsp;&nbsp;&nbsp; 2080850 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Arcus Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;379100 | &nbsp;&nbsp;&nbsp;&nbsp; 3085874 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biogen † | &nbsp;&nbsp;&nbsp;&nbsp;28000 | &nbsp;&nbsp;&nbsp;&nbsp; 3516520 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BioMarin Pharmaceutical † | &nbsp;&nbsp;&nbsp;&nbsp;110000 | &nbsp;&nbsp;&nbsp;&nbsp; 6046700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BioNTech ADR † | &nbsp;&nbsp;&nbsp;&nbsp;18000 | &nbsp;&nbsp;&nbsp;&nbsp; 1916460 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cellectis ADR † | &nbsp;&nbsp;&nbsp;&nbsp;226875 | &nbsp;&nbsp;&nbsp;&nbsp; 342581 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cogent Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;230000 | &nbsp;&nbsp;&nbsp;&nbsp; 1651400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coherus Oncology † | &nbsp;&nbsp;&nbsp;&nbsp;900000 | &nbsp;&nbsp;&nbsp;&nbsp; 658170 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compugen † | 1020000 | &nbsp;&nbsp;&nbsp;&nbsp; 1815600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cytokinetics † | &nbsp;&nbsp;&nbsp;&nbsp;40000 | &nbsp;&nbsp;&nbsp;&nbsp; 1321600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Day One Biopharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;110000 | &nbsp;&nbsp;&nbsp;&nbsp; 715000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dynavax Technologies † | &nbsp;&nbsp;&nbsp;&nbsp;570000 | &nbsp;&nbsp;&nbsp;&nbsp; 5654400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exact Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;91353 | &nbsp;&nbsp;&nbsp;&nbsp; 4854498 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fortress Biotech † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6666 | &nbsp;&nbsp;&nbsp;&nbsp; 12399 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Galmed Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1701 | &nbsp;&nbsp;&nbsp;&nbsp; 3130 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gilead Sciences | &nbsp;&nbsp;&nbsp;&nbsp;210000 | &nbsp;&nbsp;&nbsp;&nbsp; 23282700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GRAIL † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 4113600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Halozyme Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;220000 | &nbsp;&nbsp;&nbsp;&nbsp; 11444400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Immunovant † | &nbsp;&nbsp;&nbsp;&nbsp;122100 | &nbsp;&nbsp;&nbsp;&nbsp; 1953600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incyte † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 5448000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;InnoCare Pharma 144A #, † | &nbsp;&nbsp;&nbsp;&nbsp;17000 | &nbsp;&nbsp;&nbsp;&nbsp; 28370 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Instil Bio † | &nbsp;&nbsp;&nbsp;&nbsp;50000 | &nbsp;&nbsp;&nbsp;&nbsp; 1041500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intellia Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;20000 | &nbsp;&nbsp;&nbsp;&nbsp; 187600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Janux Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;76601 | &nbsp;&nbsp;&nbsp;&nbsp; 1769483 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Karyopharm Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;33333 | &nbsp;&nbsp;&nbsp;&nbsp; 143665 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MacroGenics † | &nbsp;&nbsp;&nbsp;&nbsp;420000 | &nbsp;&nbsp;&nbsp;&nbsp; 508200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Madrigal Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;15000 | &nbsp;&nbsp;&nbsp;&nbsp; 4539600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MEI Pharma † | &nbsp;&nbsp;&nbsp;&nbsp;30000 | &nbsp;&nbsp;&nbsp;&nbsp; 74100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mersana Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;150000 | &nbsp;&nbsp;&nbsp;&nbsp; 44400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moderna † | &nbsp;&nbsp;&nbsp;&nbsp;20000 | &nbsp;&nbsp;&nbsp;&nbsp; 551800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MoonLake Immunotherapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 3776000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mural Oncology † | &nbsp;&nbsp;&nbsp;&nbsp;30000 | &nbsp;&nbsp;&nbsp;&nbsp; 74100 |

---

NQ- 573 [0625] 0825 (4730775) 1

------

Schedule of investments

Macquarie Healthcare Fund

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** |
| &nbsp;&nbsp;Biotechnology (continued) | &nbsp;&nbsp;Biotechnology (continued) | &nbsp;&nbsp;Biotechnology (continued) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mustang Bio † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;160 | &nbsp;&nbsp;$153 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Myriad Genetics † | &nbsp;&nbsp;&nbsp;&nbsp;50000 | &nbsp;&nbsp;&nbsp;&nbsp; 265500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neurocrine Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 8798300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NextCure † | &nbsp;&nbsp;&nbsp;&nbsp;150000 | &nbsp;&nbsp;&nbsp;&nbsp; 69000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phio Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;50000 | &nbsp;&nbsp;&nbsp;&nbsp; 117500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ProQR Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;620000 | &nbsp;&nbsp;&nbsp;&nbsp; 1264800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Puma Biotechnology † | &nbsp;&nbsp;&nbsp;&nbsp;61255 | &nbsp;&nbsp;&nbsp;&nbsp; 210105 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regeneron Pharmaceuticals | &nbsp;&nbsp;&nbsp;&nbsp;47000 | &nbsp;&nbsp;&nbsp;&nbsp; 24675000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REGENXBIO † | &nbsp;&nbsp;&nbsp;&nbsp;149000 | &nbsp;&nbsp;&nbsp;&nbsp; 1223290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rigel Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;160000 | &nbsp;&nbsp;&nbsp;&nbsp; 2996800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rocket Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;58000 | &nbsp;&nbsp;&nbsp;&nbsp; 142100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roivant Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;338181 | &nbsp;&nbsp;&nbsp;&nbsp; 3811300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sangamo Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;400000 | &nbsp;&nbsp;&nbsp;&nbsp; 216520 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sarepta Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;11000 | &nbsp;&nbsp;&nbsp;&nbsp; 188100 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sio Gene Therapies † | &nbsp;&nbsp;&nbsp;&nbsp;64171 | &nbsp;&nbsp;&nbsp;&nbsp; 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Syndax Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;180000 | &nbsp;&nbsp;&nbsp;&nbsp; 1685700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ultragenyx Pharmaceutical † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 2545200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;uniQure † | &nbsp;&nbsp;&nbsp;&nbsp;706166 | &nbsp;&nbsp;&nbsp;&nbsp; 9843954 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;14000 | &nbsp;&nbsp;&nbsp;&nbsp; 4022900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vaxcyte † | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 2600800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vertex Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;25000 | &nbsp;&nbsp;&nbsp;&nbsp; 11130000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viking Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;330100 | &nbsp;&nbsp;&nbsp;&nbsp; 8747650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Vir Biotechnology † | &nbsp;&nbsp;&nbsp;&nbsp;220000 | &nbsp;&nbsp;&nbsp;&nbsp; 1108800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viridian Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;29370 | &nbsp;&nbsp;&nbsp;&nbsp; 410593 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Voyager Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5700 | &nbsp;&nbsp;&nbsp;&nbsp; 17727 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Xencor † | &nbsp;&nbsp;&nbsp;&nbsp;200000 | &nbsp;&nbsp;&nbsp;&nbsp; 1572000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;XOMA Royalty † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3466 | &nbsp;&nbsp;&nbsp;&nbsp; 87343 |
|  |  | &nbsp;&nbsp;&nbsp;248286718 |
| &nbsp;&nbsp;Commercial & Residential Mortgage — 3.25% | &nbsp;&nbsp;Commercial & Residential Mortgage — 3.25% | &nbsp;&nbsp;Commercial & Residential Mortgage — 3.25% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fannie Mae † | 1300000 | &nbsp;&nbsp;&nbsp;&nbsp; 12402000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Federal Home Loan Mortgage † | 1050000 | &nbsp;&nbsp;&nbsp;&nbsp; 8652000 |
|  |  | &nbsp;&nbsp;&nbsp; 21054000 |
| &nbsp;&nbsp;Electronic Equipment & Instrument — 0.06% | &nbsp;&nbsp;Electronic Equipment & Instrument — 0.06% | &nbsp;&nbsp;Electronic Equipment & Instrument — 0.06% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Topcon | &nbsp;&nbsp;&nbsp;&nbsp;16800 | &nbsp;&nbsp;&nbsp;&nbsp; 381020 |
|  |  | &nbsp;&nbsp;&nbsp; 381020 |
| &nbsp;&nbsp;Gold — 0.17% | &nbsp;&nbsp;Gold — 0.17% | &nbsp;&nbsp;Gold — 0.17% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cia de Minas Buenaventura ADR | &nbsp;&nbsp;&nbsp;&nbsp;66353 | &nbsp;&nbsp;&nbsp;&nbsp; 1089516 |
|  |  | &nbsp;&nbsp;&nbsp; 1089516 |

---

2 NQ- 573 [0625] 0825 (4730775)

------

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** |
| &nbsp;&nbsp;Healthcare Equipment — 8.35% | &nbsp;&nbsp;Healthcare Equipment — 8.35% | &nbsp;&nbsp;Healthcare Equipment — 8.35% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Boston Scientific † | &nbsp;&nbsp;&nbsp;&nbsp;380000 | &nbsp;&nbsp;$40815800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stryker | &nbsp;&nbsp;&nbsp;&nbsp;15000 | &nbsp;&nbsp;&nbsp;&nbsp; 5934450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zimmer Biomet Holdings | &nbsp;&nbsp;&nbsp;&nbsp;80000 | &nbsp;&nbsp;&nbsp;&nbsp; 7296800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zimvie † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8000 | &nbsp;&nbsp;&nbsp;&nbsp; 74800 |
|  |  | &nbsp;&nbsp;&nbsp; 54121850 |
| &nbsp;&nbsp;Healthcare Services — 1.90% | &nbsp;&nbsp;Healthcare Services — 1.90% | &nbsp;&nbsp;Healthcare Services — 1.90% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CVS Health | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 6898000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quest Diagnostics | &nbsp;&nbsp;&nbsp;&nbsp;30000 | &nbsp;&nbsp;&nbsp;&nbsp; 5388900 |
|  |  | &nbsp;&nbsp;&nbsp; 12286900 |
| &nbsp;&nbsp;Interactive Home Entertainment — 0.80% | &nbsp;&nbsp;Interactive Home Entertainment — 0.80% | &nbsp;&nbsp;Interactive Home Entertainment — 0.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sohu.com ADR † | &nbsp;&nbsp;&nbsp;&nbsp;390722 | &nbsp;&nbsp;&nbsp;&nbsp; 5200510 |
|  |  | &nbsp;&nbsp;&nbsp; 5200510 |
| &nbsp;&nbsp;Life Sciences Tools & Services — 1.47% | &nbsp;&nbsp;Life Sciences Tools & Services — 1.47% | &nbsp;&nbsp;Life Sciences Tools & Services — 1.47% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Illumina † | &nbsp;&nbsp;&nbsp;&nbsp;100000 | &nbsp;&nbsp;&nbsp;&nbsp; 9541000 |
|  |  | &nbsp;&nbsp;&nbsp; 9541000 |
| &nbsp;&nbsp;Managed Healthcare — 7.39% | &nbsp;&nbsp;Managed Healthcare — 7.39% | &nbsp;&nbsp;Managed Healthcare — 7.39% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elevance Health | &nbsp;&nbsp;&nbsp;&nbsp;63000 | &nbsp;&nbsp;&nbsp;&nbsp; 24504480 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group | &nbsp;&nbsp;&nbsp;&nbsp;75000 | &nbsp;&nbsp;&nbsp;&nbsp; 23397750 |
|  |  | &nbsp;&nbsp;&nbsp; 47902230 |
| &nbsp;&nbsp;Personal Care Product — 0.60% | &nbsp;&nbsp;Personal Care Product — 0.60% | &nbsp;&nbsp;Personal Care Product — 0.60% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kenvue | &nbsp;&nbsp;&nbsp;&nbsp;186600 | &nbsp;&nbsp;&nbsp;&nbsp; 3905538 |
|  |  | &nbsp;&nbsp;&nbsp; 3905538 |
| &nbsp;&nbsp;Pharmaceuticals — 37.12% | &nbsp;&nbsp;Pharmaceuticals — 37.12% | &nbsp;&nbsp;Pharmaceuticals — 37.12% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Arvinas † | &nbsp;&nbsp;&nbsp;&nbsp;180000 | &nbsp;&nbsp;&nbsp;&nbsp; 1324800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca | &nbsp;&nbsp;&nbsp;&nbsp;131243 | &nbsp;&nbsp;&nbsp;&nbsp; 18231251 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Atea Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;70000 | &nbsp;&nbsp;&nbsp;&nbsp; 252000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chugai Pharmaceutical | &nbsp;&nbsp;&nbsp;&nbsp;500000 | &nbsp;&nbsp;&nbsp;&nbsp; 26127565 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eli Lilly & Co. | &nbsp;&nbsp;&nbsp;&nbsp;56000 | &nbsp;&nbsp;&nbsp;&nbsp; 43653680 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Euroapi † | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8695 | &nbsp;&nbsp;&nbsp;&nbsp; 29559 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Johnson & Johnson | &nbsp;&nbsp;&nbsp;&nbsp;50000 | &nbsp;&nbsp;&nbsp;&nbsp; 7637500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landos Biopharma † | &nbsp;&nbsp;&nbsp;&nbsp;14718 | &nbsp;&nbsp;&nbsp;&nbsp; 36942 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merck & Co. | &nbsp;&nbsp;&nbsp;&nbsp;310000 | &nbsp;&nbsp;&nbsp;&nbsp; 24539600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nektar Therapeutics | &nbsp;&nbsp;&nbsp;&nbsp;17092 | &nbsp;&nbsp;&nbsp;&nbsp; 441668 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Organon & Co. | &nbsp;&nbsp;&nbsp;&nbsp;29500 | &nbsp;&nbsp;&nbsp;&nbsp; 285560 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Perrigo | &nbsp;&nbsp;&nbsp;&nbsp;230000 | &nbsp;&nbsp;&nbsp;&nbsp; 6145600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pfizer | 1145000 | &nbsp;&nbsp;&nbsp;&nbsp; 27754800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roche Holding | &nbsp;&nbsp;&nbsp;&nbsp;75000 | &nbsp;&nbsp;&nbsp;&nbsp; 24424980 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sanofi | &nbsp;&nbsp;&nbsp;&nbsp;165423 | &nbsp;&nbsp;&nbsp;&nbsp; 16019442 |

---

NQ- 573 [0625] 0825 (4730775) 3

------

Schedule of investments

Macquarie Healthcare Fund

---

| | | |
|:---|:---|:---|
|  | Number of<br> shares | &nbsp;&nbsp;Value (US $) |
| &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** | &nbsp;&nbsp;**Common Stocks♣ (continued)** |
| &nbsp;&nbsp;Pharmaceuticals (continued) | &nbsp;&nbsp;Pharmaceuticals (continued) | &nbsp;&nbsp;Pharmaceuticals (continued) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Structure Therapeutics ADR † | &nbsp;&nbsp;&nbsp;&nbsp;58000 | &nbsp;&nbsp;$1202920 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tarsus Pharmaceuticals † | &nbsp;&nbsp;&nbsp;&nbsp;150000 | &nbsp;&nbsp;&nbsp;&nbsp; 6076500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Theravance Biopharma † | &nbsp;&nbsp;&nbsp;&nbsp;208783 | &nbsp;&nbsp;&nbsp;&nbsp; 2302876 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UCB | &nbsp;&nbsp;&nbsp;&nbsp;112137 | &nbsp;&nbsp;&nbsp;&nbsp; 22052723 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ventyx Biosciences † | &nbsp;&nbsp;&nbsp;&nbsp;430000 | &nbsp;&nbsp;&nbsp;&nbsp; 920200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Viatris | 1170018 | &nbsp;&nbsp;&nbsp;&nbsp; 10448261 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WaVe Life Sciences † | &nbsp;&nbsp;&nbsp;&nbsp;81955 | &nbsp;&nbsp;&nbsp;&nbsp; 532708 |
|  |  | &nbsp;&nbsp;&nbsp;240441135 |
| &nbsp;&nbsp;&nbsp;**Total Common Stocks (cost $531,368,388)** | &nbsp;&nbsp;&nbsp;**Total Common Stocks (cost $531,368,388)** | &nbsp;&nbsp;&nbsp;**644210417** |
| &nbsp;&nbsp;**Rights — 0.01%** | &nbsp;&nbsp;**Rights — 0.01%** | &nbsp;&nbsp;**Rights — 0.01%** |
| &nbsp;&nbsp;Biotechnology — 0.01% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ambit Bioscience =, †, π | &nbsp;&nbsp;&nbsp;&nbsp;76500 | &nbsp;&nbsp;&nbsp;&nbsp; 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contra Surface Oncolog † | &nbsp;&nbsp;&nbsp;&nbsp;350000 | &nbsp;&nbsp;&nbsp;&nbsp; 26950 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mirati Therapeutics † | &nbsp;&nbsp;&nbsp;&nbsp;60000 | &nbsp;&nbsp;&nbsp;&nbsp; 42000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yumanity Therapeutics =, † | &nbsp;&nbsp;&nbsp;&nbsp;750000 | &nbsp;&nbsp;&nbsp;&nbsp; 0 |
| &nbsp;&nbsp;&nbsp;**Total Rights (cost $0)** | &nbsp;&nbsp;&nbsp;**Total Rights (cost $0)** | &nbsp;&nbsp;&nbsp; **68950** |
| &nbsp;&nbsp;**Short-Term Investments — 0.26%** | &nbsp;&nbsp;**Short-Term Investments — 0.26%** | &nbsp;&nbsp;**Short-Term Investments — 0.26%** |
| &nbsp;&nbsp;Money Market Mutual Funds — 0.26% | &nbsp;&nbsp;Money Market Mutual Funds — 0.26% | &nbsp;&nbsp;Money Market Mutual Funds — 0.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BlackRock Liquidity FedFund – Institutional Shares (seven-day effective yield 4.22%) | &nbsp;&nbsp;&nbsp;&nbsp;410395 | &nbsp;&nbsp;&nbsp;&nbsp; 410395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fidelity Investments Money Market Government Portfolio – Class I (seven-day effective yield 4.23%) | &nbsp;&nbsp;&nbsp;&nbsp;410395 | &nbsp;&nbsp;&nbsp;&nbsp; 410395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goldman Sachs Financial Square Government Fund – Institutional Shares (seven-day effective yield 4.30%) | &nbsp;&nbsp;&nbsp;&nbsp;410395 | &nbsp;&nbsp;&nbsp;&nbsp; 410395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Morgan Stanley Institutional Liquidity Funds Government Portfolio – Institutional Class (seven-day effective yield 4.23%) | &nbsp;&nbsp;&nbsp;&nbsp;410395 | &nbsp;&nbsp;&nbsp;&nbsp; 410395 |
| &nbsp;&nbsp;&nbsp;**Total Short-Term Investments (cost $1,641,580)** | &nbsp;&nbsp;&nbsp;**Total Short-Term Investments (cost $1,641,580)** | &nbsp;&nbsp;&nbsp; **1641580** |
| &nbsp;&nbsp;&nbsp;**Total Value of Securities—99.71%<br> (cost $533,009,968)** |  | &nbsp;&nbsp;&nbsp;&nbsp;**645920947** |
| &nbsp;&nbsp;&nbsp;**Receivables and Other Assets Net of Liabilities—0.29%** |  | &nbsp;&nbsp;&nbsp;&nbsp; **1902908** |
| &nbsp;&nbsp;&nbsp;**Net Assets Applicable to 27,876,756 Shares Outstanding—100.00%** |  | &nbsp;&nbsp;**$647823855** |

---

♣ Categorizations used for financial reporting purposes may differ from categorizations used for regulatory compliance and/or internal classification purposes. <br> † Non-income producing security.

4 NQ- 573 [0625] 0825 (4730775)

------

---

| |
|:---|
| Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. At June 30, 2025, the aggregate value of Rule 144A securities was $28,370, which represents 0.00% of the Fund's net assets. |
| The value of this security was determined using significant unobservable inputs and is reported as a Level 3 security. |
| Restricted security. These investments are in securities not registered under the Securities Act of 1933, as amended, and have certain restrictions on resale which may limit their liquidity. At June 30, 2025, the aggregate value of restricted securities was $0, which represented 0.00% of the Fund's net assets. See table below for additional details on restricted securities. |

---

---

| | | | |
|:---|:---|:---|:---|
| **Restricted Securities** |  |  |  |
| Investments | &nbsp;&nbsp;Date of Acquisition | &nbsp;&nbsp;Cost | &nbsp;&nbsp;Value |
| Ambit Bioscience | &nbsp;&nbsp;11/12/14 | &nbsp;&nbsp;$0 | &nbsp;&nbsp;$0 |

---

---

| |
|:---|
| **Summary of abbreviations:** |
| ADR – American Depositary Receipt |

---

NQ- 573 [0625] 0825 (4730775) 5

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Delaware Group Equity Funds IV

- **b. Investment Company Act file number:** 811-04413

- **c. CIK number of Registrant:** 0000778108

- **d. LEI of Registrant:** 549300OT9UDUW3MXT836

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 100 Independence

  - **City:** Philadelphia

  - **State:** PA

  - **Foreign country:** US

  - **Zip / Postal Code:** 19106-2354

  - **Telephone number:** 800-523-1918

**Item A.2. Information about the Series.**

- **a. Name of Series:** Macquarie Healthcare Fund

- **b. EDGAR series identifier (if any):** S000018873

- **c. LEI of Series:** 3T01W8DZEUUPS0D3VS95

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $649280578.23

**Total Liabilities:** $1256751.48

**Net Assets:** $648023826.75

**Cash Not Reported:** $116002.11

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000052257 | 0.08%                | -5.00%               | 1.80%                |
| Class ID C000052258 | 0.05%                | -5.11%               | 1.75%                |
| Class ID C000052259 | 0.09%                | -5.08%               | 1.81%                |
| Class ID C000052260 | 0.12%                | -5.03%               | 1.82%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $11809697.14             | $-11760743.48                              |
| Month 2  | $0.00                    | $-35929292.97                              |
| Month 3  | $14958135.70             | $-3877201.41                               |

### Schedule of Portfolio Investments

| Name                                           | Title                                          | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Phio Pharmaceuticals Corp                      | Phio Pharmaceuticals Corp                      | CUSIP: 71880W501<br>LEI: 549300KOGMLSPLDVHR52 | Long             | EC               | CORP              | US        |     50000 | NS      | $117500.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Financial Square Government Fund | Goldman Sachs Financial Square Government Fund | CUSIP: 38141W273<br>LEI: 549300BRJMXN4GUWZ402 | Long             | STIV             | RF                | US        |    410395 | NS      | $410394.92    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Proteostasis Theapeutics                       | Proteostasis Theapeutics                       | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    750000 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Fortress Biotech Inc                           | Fortress Biotech Inc                           | CUSIP: 34960Q307<br>LEI: 529900DZUWSYUURECK24 | Long             | EC               | CORP              | US        |      6666 | NS      | $12398.76     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Karyopharm Therapeutics Inc                    | Karyopharm Therapeutics Inc                    | CUSIP: 48576U205<br>LEI: 549300J1VANRCNTYST87 | Long             | EC               | CORP              | US        |     33333 | NS      | $143665.23    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc                         | Cogent Biosciences Inc                         | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    230000 | NS      | $1651400.00   | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics                    | MoonLake Immunotherapeutics                    | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | CH        |     80000 | NS      | $3776000.00   | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                                   | Stryker Corp                                   | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     15000 | NS      | $5934450.00   | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd                         | WaVe Life Sciences Ltd                         | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | US        |     81955 | NS      | $532707.50    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Mustang Bio Inc                                | Mustang Bio Inc                                | CUSIP: 62818Q302<br>LEI: 5493004W0VC1DPECQ779 | Long             | EC               | CORP              | US        |       160 | NS      | $152.82       | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                                   | Alkermes PLC                                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |    300000 | NS      | $8583000.00   | 1.32%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                     | AbbVie Inc                                     | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    125000 | NS      | $23202500.00  | 3.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                    | Alnylam Pharmaceuticals Inc                    | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     30000 | NS      | $9782700.00   | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Amarin Corp PLC                                | Amarin Corp PLC                                | CUSIP: 023111404<br>LEI: 5493009JFIGUFEVPK217 | Long             | EC               | CORP              | IE        |      9500 | NS      | $154090.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Galmed Pharmaceuticals Ltd                     | Galmed Pharmaceuticals Ltd                     | CUSIP: 000000000<br>LEI: 549300FL07PJ8ICSMD04 | Long             | EC               | CORP              | IL        |      1701 | NS      | $3129.84      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Cia de Minas Buenaventura SAA                  | Cia de Minas Buenaventura SAA                  | CUSIP: 204448104<br>LEI: 529900WQB1ZU9KB6EL71 | Long             | EC               | CORP              | PE        |     66353 | NS      | $1089516.26   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                    | Incyte Corp                                    | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     80000 | NS      | $5448000.00   | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics Inc                               | Cytokinetics Inc                               | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |     40000 | NS      | $1321600.00   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| MIRATI THERAPEUTICS INC                        | MIRATI THERAPEUTICS INC                        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     60000 | NS      | $42000.00     | 0.01%             |  |  |  | No            |                  2 | On Loan: No      |
| Theravance Biopharma Inc                       | Theravance Biopharma Inc                       | CUSIP: 000000000<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |    208783 | NS      | $2302876.49   | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc                          | Arcus Biosciences Inc                          | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    379100 | NS      | $3085874.00   | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc                     | Tarsus Pharmaceuticals Inc                     | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    150000 | NS      | $6076500.00   | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                                 | Perrigo Co PLC                                 | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    230000 | NS      | $6145600.00   | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics Inc                      | Viridian Therapeutics Inc                      | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |     29370 | NS      | $410592.60    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| GRAIL Inc                                      | GRAIL Inc                                      | CUSIP: 384747101<br>LEI: 2549009XSNESW3VE8024 | Long             | EC               | CORP              | US        |     80000 | NS      | $4113600.00   | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Mersana Therapeutics Inc                       | Mersana Therapeutics Inc                       | CUSIP: 59045L106<br>LEI: 529900VWD5VDZ7PVOS22 | Long             | EC               | CORP              | US        |    150000 | NS      | $44400.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                     | Zimmer Biomet Holdings Inc                     | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |     80000 | NS      | $7296800.00   | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Compugen Ltd                                   | Compugen Ltd                                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IL        |   1020000 | NS      | $1815600.00   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Government Portfolio                  | Fidelity Government Portfolio                  | CUSIP: 316175108<br>LEI: 549300FQDFZGLUOCWN51 | Long             | STIV             | RF                | US        |    410395 | NS      | $410394.92    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| AMBIT BIOSCIENCES CORP CVR                     | AMBIT BIOSCIENCES CORP CVR                     | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     76500 | NS      | $0.00         | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Boston Scientific Corp                         | Boston Scientific Corp                         | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    380000 | NS      | $40815800.00  | 6.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Topcon Corp                                    | Topcon Corp                                    | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |     16800 | NS      | $381020.10    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Myriad Genetics Inc                            | Myriad Genetics Inc                            | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |     50000 | NS      | $265500.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| ProQR Therapeutics NV                          | ProQR Therapeutics NV                          | CUSIP: 000000000<br>LEI: 549300NGS2FJGGDBGS06 | Long             | EC               | CORP              | NL        |    620000 | NS      | $1264800.00   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimvie Inc                                     | Zimvie Inc                                     | CUSIP: 98888T107<br>LEI: 549300GFKURT1J6XR665 | Long             | EC               | CORP              | US        |      8000 | NS      | $74800.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Atea Pharmaceuticals Inc                       | Atea Pharmaceuticals Inc                       | CUSIP: 04683R106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     70000 | NS      | $252000.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                    | BioMarin Pharmaceutical Inc                    | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |    110000 | NS      | $6046700.00   | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                 | Eli Lilly & Co                                 | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     57000 | NS      | $44433210.00  | 6.86%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                                     | uniQure NV                                     | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |    706166 | NS      | $9843954.04   | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENXBIO Inc                                  | REGENXBIO Inc                                  | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |    149000 | NS      | $1223290.00   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                     | Neurocrine Biosciences Inc                     | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     70000 | NS      | $8798300.00   | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                                         | UCB SA                                         | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |    112137 | NS      | $22052722.53  | 3.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Puma Biotechnology Inc                         | Puma Biotechnology Inc                         | CUSIP: 74587V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     61255 | NS      | $210104.65    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics Inc                         | Akero Therapeutics Inc                         | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |     39478 | NS      | $2106546.08   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                  | Regeneron Pharmaceuticals Inc                  | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     47000 | NS      | $24675000.00  | 3.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                      | Halozyme Therapeutics Inc                      | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |    220000 | NS      | $11444400.00  | 1.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                     | Biogen Inc                                     | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     28000 | NS      | $3516520.00   | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                                     | Pfizer Inc                                     | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   1145000 | NS      | $27754800.00  | 4.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Instil Bio Inc                                 | Instil Bio Inc                                 | CUSIP: 45783C200<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     50000 | NS      | $1041500.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                                 | Immunovant Inc                                 | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    122100 | NS      | $1953600.00   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Voyager Therapeutics Inc                       | Voyager Therapeutics Inc                       | CUSIP: 92915B106<br>LEI: 54930082S4XVR0ZWCC74 | Long             | EC               | CORP              | US        |      5700 | NS      | $17727.00     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp                            | Exact Sciences Corp                            | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |     91353 | NS      | $4854498.42   | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                | AstraZeneca PLC                                | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    131243 | NS      | $18231251.24  | 2.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Quest Diagnostics Inc                          | Quest Diagnostics Inc                          | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     30000 | NS      | $5388900.00   | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                     | Vertex Pharmaceuticals Inc                     | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     25000 | NS      | $11130000.00  | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc                            | Elevance Health Inc                            | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |     63000 | NS      | $24504480.00  | 3.78%             |  |  |  | No            |                  1 | On Loan: No      |
| InnoCare Pharma Ltd                            | InnoCare Pharma Ltd                            | CUSIP: 000000000<br>LEI: 3003001NYJPPWIEOJT79 | Long             | EC               | CORP              | CN        |     17000 | NS      | $28369.61     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                                    | Viatris Inc                                    | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |   1170018 | NS      | $10448260.74  | 1.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                              | Johnson & Johnson                              | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     50000 | NS      | $7637500.00   | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                   | Madrigal Pharmaceuticals Inc                   | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |     15000 | NS      | $4539600.00   | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| LANDOS BIOPHARMA INC                           | LANDOS BIOPHARMA INC                           | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14718 | NS      | $36942.18     | 0.01%             |  |  |  | No            |                  2 | On Loan: No      |
| Xencor Inc                                     | Xencor Inc                                     | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |    200000 | NS      | $1572000.00   | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                                | CVS Health Corp                                | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    100000 | NS      | $6898000.00   | 1.06%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp                       | United Therapeutics Corp                       | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     14000 | NS      | $4022900.00   | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                            | Gilead Sciences Inc                            | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    210000 | NS      | $23282700.00  | 3.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Day One Biopharmaceuticals Inc                 | Day One Biopharmaceuticals Inc                 | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    110000 | NS      | $715000.00    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Kenvue Inc                                     | Kenvue Inc                                     | CUSIP: 49177J102<br>LEI: 5493008HSF8L4M2LIJ82 | Long             | EC               | CORP              | US        |    186600 | NS      | $3905538.00   | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                                    | Arvinas Inc                                    | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    180000 | NS      | $1324800.00   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                                   | Organon & Co                                   | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |     29500 | NS      | $285560.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                                    | BioNTech SE                                    | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |     18000 | NS      | $1916460.00   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Fannie Mae                                     | Federal National Mortgage Association          | CUSIP: 313586109<br>LEI: B1V7KEBTPIMZEU4LTD58 | Long             | EC               | USGSE             | US        |   1300000 | NS      | $12402000.00  | 1.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                                 | Merck & Co Inc                                 | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    310000 | NS      | $24539600.00  | 3.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Dynavax Technologies Corp                      | Dynavax Technologies Corp                      | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |    570000 | NS      | $5654400.00   | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Ventyx Biosciences Inc                         | Ventyx Biosciences Inc                         | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    430000 | NS      | $920200.00    | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                                      | Sanofi SA                                      | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    165423 | NS      | $16019442.48  | 2.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc                      | Allogene Therapeutics Inc                      | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    146779 | NS      | $165860.27    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Coherus Oncology Inc                           | Coherus Oncology Inc                           | CUSIP: 19249H103<br>LEI: 5493007IL8W5MV932D26 | Long             | EC               | CORP              | US        |    900000 | NS      | $658170.00    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                   | Illumina Inc                                   | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    100000 | NS      | $9541000.00   | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                      | Amgen Inc                                      | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     77000 | NS      | $21499170.00  | 3.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                    | Moderna Inc                                    | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |     20000 | NS      | $551800.00    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc                        | Viking Therapeutics Inc                        | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |    330100 | NS      | $8747650.00   | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                                 | AnaptysBio Inc                                 | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |     93732 | NS      | $2080850.40   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Sohu.com Ltd                                   | Sohu.com Ltd                                   | CUSIP: 83410S108<br>LEI: N/A                  | Long             | EC               | CORP              | CN        |    390722 | NS      | $5200509.82   | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| NextCure Inc                                   | NextCure Inc                                   | CUSIP: 65343E108<br>LEI: 549300Y5PR6RJR1STI24 | Long             | EC               | CORP              | US        |    150000 | NS      | $69000.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics Inc                         | Janux Therapeutics Inc                         | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     76601 | NS      | $1769483.10   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd                   | Chugai Pharmaceutical Co Ltd                   | CUSIP: 000000000<br>LEI: 529900T9LAII161DCN95 | Long             | EC               | CORP              | JP        |    500000 | NS      | $26127565.02  | 4.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                                    | Vaxcyte Inc                                    | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |     80000 | NS      | $2600800.00   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| MacroGenics Inc                                | MacroGenics Inc                                | CUSIP: 556099109<br>LEI: 5493001KJQUA83L8MH79 | Long             | EC               | CORP              | US        |    420000 | NS      | $508200.00    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| MSILF Government Portfolio                     | MSILF Government Portfolio                     | CUSIP: 61747C707<br>LEI: 549300BI6Y5SI6BYPB26 | Long             | STIV             | RF                | US        |    410395 | NS      | $410394.93    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Structure Therapeutics Inc                     | Structure Therapeutics Inc                     | CUSIP: 86366E106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     58000 | NS      | $1202920.00   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Rigel Pharmaceuticals Inc                      | Rigel Pharmaceuticals Inc                      | CUSIP: 766559702<br>LEI: 529900KPTNUS5J8K9K66 | Long             | EC               | CORP              | US        |    160000 | NS      | $2996800.00   | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Altimmune Inc                                  | Altimmune Inc                                  | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |    100000 | NS      | $387000.00    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Liquidity FedFund                    | BlackRock Liquidity FedFund                    | CUSIP: 09248U700<br>LEI: 549300T8K043VZEOVK74 | Long             | STIV             | RF                | US        |    410395 | NS      | $410394.92    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| MEI Pharma Inc                                 | MEI Pharma Inc                                 | CUSIP: 55279B301<br>LEI: 529900A43X33ON524197 | Long             | EC               | CORP              | US        |     30000 | NS      | $74100.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals Inc                     | ACADIA Pharmaceuticals Inc                     | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |     92648 | NS      | $1998417.36   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                               | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     75000 | NS      | $24424979.52  | 3.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                      | Intellia Therapeutics Inc                      | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     20000 | NS      | $187600.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Rocket Pharmaceuticals Inc                     | Rocket Pharmaceuticals Inc                     | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |     58000 | NS      | $142100.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Herc Holdings Inc                              | Herc Holdings Inc                              | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |     17092 | NS      | $441668.10    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Mural Oncology PLC                             | Mural Oncology PLC                             | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     30000 | NS      | $74100.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| SIO GENE THERAPIES INC                         | SIO GENE THERAPIES INC                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     64171 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Freddie Mac                                    | Federal Home Loan Mortgage Corp                | CUSIP: 313400301<br>LEI: S6XOOCT0IEG5ABCC6L87 | Long             | EC               | USGSE             | US        |   1050000 | NS      | $8652000.00   | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                  | Ultragenyx Pharmaceutical Inc                  | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     70000 | NS      | $2545200.00   | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Cellectis SA                                   | Cellectis SA                                   | CUSIP: 15117K103<br>LEI: 5493000KKX5VQ37Q2W83 | Long             | EC               | CORP              | FR        |    226875 | NS      | $342581.25    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| XOMA Royalty Corp                              | XOMA Royalty Corp                              | CUSIP: 98419J206<br>LEI: 549300U6ZVYFCWNBJ613 | Long             | EC               | CORP              | US        |      3466 | NS      | $87343.20     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Sangamo Therapeutics Inc                       | Sangamo Therapeutics Inc                       | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               | CORP              | US        |    400000 | NS      | $216520.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc                       | Sarepta Therapeutics Inc                       | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |     11000 | NS      | $188100.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd                           | Roivant Sciences Ltd                           | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | US        |    338181 | NS      | $3811299.87   | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc                     | Syndax Pharmaceuticals Inc                     | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |    180000 | NS      | $1685700.00   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc                          | Vir Biotechnology Inc                          | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    220000 | NS      | $1108800.00   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Euroapi SA                                     | Euroapi SA                                     | CUSIP: 000000000<br>LEI: 9695002FT7GGI3CKKJ14 | Long             | EC               | CORP              | FR        |      8695 | NS      | $29559.21     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                         | UnitedHealth Group Inc                         | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     75000 | NS      | $23397750.00  | 3.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Contra Surface Oncolog                         | Contra Surface Oncolog                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    350000 | NS      | $26950.00     | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |

### Signature

**Date Signed:** 2025-08-25

**Name of Applicant:** Delaware Group Equity Funds IV

**Signature:** Dan Geatens

**Name of Signer:** Dan Geatens

**Title:** Division Director - Head of US Fund Administration